Title : Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro.

Pub. Date : 2021 Nov 11

PMID : 33330868






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We found that thiol-based drugs, cysteamine and WR-1065 (the active metabolite of amifostine) in particular, decrease binding of SARS-CoV-2 spike protein to its receptor, decrease the entry efficiency of SARS-CoV-2 spike pseudotyped virus, and inhibit SARS-CoV-2 live virus infection. N-(2-mercaptoethyl)-1,3-diaminopropane surface glycoprotein Severe acute respiratory syndrome coronavirus 2
2 We found that thiol-based drugs, cysteamine and WR-1065 (the active metabolite of amifostine) in particular, decrease binding of SARS-CoV-2 spike protein to its receptor, decrease the entry efficiency of SARS-CoV-2 spike pseudotyped virus, and inhibit SARS-CoV-2 live virus infection. N-(2-mercaptoethyl)-1,3-diaminopropane surface glycoprotein Severe acute respiratory syndrome coronavirus 2